CIK 0001626878
- Non-accelerated filer
- Smaller reporting company
XBiotech Inc.
Sign in to watch- Ticker
- XBIT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 512-386-2900
- Business address
- 5217 WINNEBAGO LANE, AUSTIN, TX, 78744
- Open-market buys, last 90 days
- $854,660
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$854,660. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | SIMARD JOHN Director | Purchase | +70,000 | $2.05 | $143K | 4,261,690 |
| 2026-10-26 | Simard Jan-Paul Co-Chief Executive Officer | Grant or award · Stock Option | +2,000,000 | 2,000,000 | ||
| 2026-10-26 | SIMARD JOHN Director | Purchase | +368,524 | $1.93 | $711K | 4,191,690 |
| 2025-10-01 | Rademaker Craig Evan Director | Grant or award · Director Stock Option | +92,104 | 92,104 | ||
| 2025-10-01 | Soffer David Spencer Director | Grant or award · Director Stock Option | +51,000 | 51,000 | ||
| 2025-10-01 | Kuendig Thomas Martin Director | Grant or award · Director Stock Option | +79,115 | 79,115 | ||
| 2025-10-01 | Troy Tevi David Director | Grant or award · Director Stock Option | +56,000 | 56,000 | ||
| 2025-03-17 | SIMARD JOHN Chief Executive Officer | Grant or award · Stock Option | +1,026,228 | 1,896,609 | ||
| 2025-01-31 | SIMARD JOHN Chief Executive Officer | Other disposition · Convertible Loan Agreement | −2,470,355 | $10,000,000.00 | $24703.5B | 870,381 |
| 2024-06-20 | MCKENZIE W THORPE Director | Grant or award · Director Stock Option | +37,500 | 37,500 | ||
| 2024-06-20 | Waldin Jan-Paul Director | Grant or award · Director Stock Option | +37,500 | 37,500 | ||
| 2024-06-20 | MacAdam Donald H. Director | Grant or award · Director Stock Option | +37,500 | 37,500 | ||
| 2024-06-20 | Libby Peter Director | Grant or award · Director Stock Option | +37,500 | 37,500 | ||
| 2024-01-03 | SIMARD JOHN Chief Executive Officer | Purchase · Convertible Loan Agreement | +2,470,355 | $10,000,000.00 | $24703.5B | 3,840,736 |
| 2023-06-23 | Waldin Jan-Paul Director | Grant or award · Director Stock Option | +25,000 | 25,000 | ||
| 2023-06-23 | Libby Peter Director | Grant or award · Director Stock Option | +25,000 | 25,000 | ||
| 2023-06-23 | MacAdam Donald H. Director | Grant or award · Director Stock Option | +25,000 | 25,000 | ||
| 2023-06-23 | MCKENZIE W THORPE Director | Grant or award · Director Stock Option | +25,000 | 25,000 | ||
| 2023-02-10 | SHIVASWAMY SUSHMA Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-22 | MacAdam Donald H. Director | Grant or award · Stock Option | +25,000 | 25,000 |
Page 1 of 14 · 273 trades